日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stable laser-acceleration of high-flux proton beams with plasma collimation

利用等离子体准直实现高通量质子束的稳定激光加速

Streeter, M J V; Glenn, G D; DiIorio, S; Treffert, F; Loughran, B; Ahmed, H; Astbury, S; Borghesi, M; Bourgeois, N; Curry, C B; Dann, S J D; Dover, N P; Dzelzainis, T; Ettlinger, O C; Gauthier, M; Giuffrida, L; Glenzer, S H; Gray, R J; Green, J S; Hicks, G S; Hyland, C; Istokskaia, V; King, M; Margarone, D; McCusker, O; McKenna, P; Najmudin, Z; Parisuaña, C; Parsons, P; Spindloe, C; Symes, D R; Thomas, A G R; Xu, N; Palmer, C A J

[Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review]

[采用DVT方案治疗浆细胞样树突状细胞瘤:病例报告及文献复习]

Shi, J; Xu, N; Niu, Y; Jia, S X; Yang, C M; Fang, M Y

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]

【酪氨酸激酶抑制剂治疗新诊断慢性粒细胞白血病的现状:一项国内多中心回顾性真实世界研究】

Zhang, X S; Liu, B C; Du, X; Zhang, Y L; Xu, N; Liu, X L; Li, W M; Lin, H; Liang, R; Chen, C Y; Huang, J; Yang, Y F; Zhu, H L; Pan, L; Wang, X D; Li, G H; Liu, Z G; Zhang, Y Q; Liu, Z F; Hu, J D; Liu, C S; Li, F; Yang, W; Meng, L; Han, Y Q; Lin, L E; Zhao, Z Y; Tu, C Q; Zheng, C F; Bai, Y L; Zhou, Z P; Chen, S N; Qiu, H Y; Yang, L J; Sun, X L; Sun, H; Zhou, L; Liu, Z L; Wang, D Y; Guo, J X; Pang, L P; Zeng, Q S; Suo, X H; Zhang, W H; Zheng, Y J; Jiang, Q

[Early cellular immune exhaustion in patients with Epstein-Barr virus activation following haploidentical hematopoietic stem cell transplantation]

[单倍体造血干细胞移植后,Epstein-Barr病毒激活患者早期细胞免疫耗竭]

Huang, Y F; Zhang, S Y; He, J B; Zhou, Y; Xue, R T; Fan, Z P; Huang, F; Xu, N; Sun, J; Liu, Q F; Lin, R

[Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation]

[异基因造血干细胞移植后卡氏肺囊虫肺炎的宏基因组二代测序诊断]

Fu, R; Lin, R; Fan, Z P; Huang, F; Xu, N; Xuan, L; Huang, Y F; Liu, H; Zhao, K; Wang, Z X; Jiang, L; Dai, M; Sun, J; Liu, Q F

First-in-human, phase I study of AK109, an anti-VEGFR2 antibody in patients with advanced or metastatic solid tumors

AK109(一种抗VEGFR2抗体)在晚期或转移性实体瘤患者中的首次人体I期研究

Zheng, Y; Zhong, H; Zhao, F; Zhou, H; Mao, C; Lv, W; Yuan, M; Qian, J; Jiang, H; Wang, Z; Xiao, C; Guo, J; Liu, T; Liu, W; Wang, Z M; Li, B; Xia, M; Xu, N

Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials

Suvemcitug 作为晚期或转移性实体瘤的二线治疗方案,以及与 FOLFIRI 联合用于既往接受过治疗的转移性结直肠癌:Ia/Ib 期开放标签、剂量递增试验

Mao, C; Ji, D; Ding, Y; Zhang, Y; Song, W; Liu, L; Wu, Y; Song, L; Feng, X; Zhang, J; Cao, J; Xu, N

FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways

FZD2 通过介导 β-catenin 依赖性和不依赖性的 Wnt 信号通路来调节肢体发育

Xuming Zhu, Mingang Xu, N Adrian Leu, Edward E Morrisey, Sarah E Millar

Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese Adults

中国成年人肌肉脂肪含量与非酒精性脂肪肝和肝纤维化相关

Guo, W; Zhao, X; Cheng, D; Liang, X; Miao, M; Li, X; Lu, J; Xu, N; Hu, S; Zhang, Q

[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]

[年轻骨髓增生性肿瘤患者的临床和遗传特征]

Zhang, M Y; Bao, M; Shi, D Y; Shi, H X; Liu, X L; Xu, N; Duan, M H; Zhuang, J L; Du, X; Qin, L; Hui, W H; Liang, R; Wang, M F; Chen, Y; Li, D Y; Yang, W; Tang, G S; Zhang, W H; Kuang, X; Su, W; Han, Y Q; Chen, L M; Xu, J H; Liu, Z G; Huang, J; Zhao, C T; Tong, H Y; Hu, J D; Chen, C Y; Chen, X Q; Xiao, Z J; Jiang, Q